Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 6, Pages 1422
Publisher
MDPI AG
Online
2021-03-22
DOI
10.3390/cancers13061422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma
- (2020) Haijing Deng et al. Liver Cancer
- The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
- (2020) Navid Sobhani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor
- (2020) Annalisa Astolfi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
- (2020) Josep Garcia et al. CANCER TREATMENT REVIEWS
- FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
- (2020) Jae Hong Im et al. Nature Communications
- Angiogenesis Inhibition in Prostate Cancer: An Update
- (2020) Chandrani Sarkar et al. Cancers
- Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation
- (2020) De-Li ZhuGe et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma
- (2020) Alessio Ardizzone et al. Cancers
- Treatment with Brivanib alaninate as a second-line monotherapy after Sorafenib failure in hepatocellular carcinoma
- (2019) Hong Zhu et al. MEDICINE
- Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
- (2019) Hisashi Hidaka et al. MEDICAL ONCOLOGY
- Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
- (2019) Racheal G. Akwii et al. Cells
- Targeting Angiogenesis in Prostate Cancer
- (2019) Zsombor Melegh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas
- (2019) Tony Navas et al. CANCER RESEARCH
- Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism
- (2019) Jian Hua Qi et al. Scientific Reports
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis
- (2019) Dedong Cao et al. Scientific Reports
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
- (2018) Joao Incio et al. Science Translational Medicine
- Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
- (2018) Ahmed M.E. Abdalla et al. Theranostics
- Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Age-related macular degeneration
- (2018) Paul Mitchell et al. LANCET
- Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas
- (2016) Saori Okamoto et al. Brain Tumor Pathology
- Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
- (2016) Dong Li et al. CANCER LETTERS
- Commentary on Folkman: "How Is Blood Vessel Growth Regulated in Normal and Neoplastic Tissue?"
- (2016) H. G. Augustin CANCER RESEARCH
- Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment
- (2016) Ping-Pui Wong et al. CURRENT BIOLOGY
- The Complexity of Translating Anti-angiogenesis Therapy from Basic Science to the Clinic
- (2016) Weilan Ye DEVELOPMENTAL CELL
- Prediction of anti-angiogenesis escape
- (2016) Takashi Mitamura et al. GYNECOLOGIC ONCOLOGY
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism
- (2016) Minjian Zhao et al. ONCOLOGY REPORTS
- A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer
- (2016) Dan-Zeng Ba-Sang et al. Oncotarget
- Fibroblast Growth Factor Signaling in the Vasculature
- (2015) Xuehui Yang et al. Current Atherosclerosis Reports
- Pazopanib for the treatment of renal cell carcinoma
- (2015) Sarah J Welsh et al. Future Oncology
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Nintedanib in non-small cell lung cancer: from preclinical to approval
- (2015) Christian Caglevic et al. Therapeutic Advances in Respiratory Disease
- Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
- (2014) Hyun-Jin Choi et al. CANCER AND METASTASIS REVIEWS
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
- (2014) Masatoshi Kudo et al. HEPATOLOGY
- Third-line dovitinib in metastatic renal cell carcinoma
- (2014) Manuela Schmidinger LANCET ONCOLOGY
- Molecular analysis of a recurrent glioblastoma treated with bevacizumab
- (2013) Takuya Furuta et al. Brain Tumor Pathology
- Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer
- (2013) M. Dror Michaelson et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascularity of primary and metastatic renal cell carcinoma specimens
- (2013) Saadia A Aziz et al. Journal of Translational Medicine
- Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
- (2013) Ian F Tannock et al. LANCET ONCOLOGY
- A Proangiogenic Signature Is Revealed in FGF-Mediated Bevacizumab-Resistant Head and Neck Squamous Cell Carcinoma
- (2013) R. Gyanchandani et al. MOLECULAR CANCER RESEARCH
- Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
- (2013) A. A. Belov et al. Cold Spring Harbor Perspectives in Biology
- Biomarkers for antitumor activity of bevacizumab in gastric cancer models
- (2012) Yoriko Yamashita-Kashima et al. BMC CANCER
- The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells
- (2012) Awatef Ben Jemaa et al. INFLAMMATION
- Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
- (2012) M. Shibuya JOURNAL OF BIOCHEMISTRY
- Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients
- (2012) Camillo Porta et al. ONCOLOGY
- E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
- (2011) Ezia Bello et al. CANCER RESEARCH
- Metformin, diet and breast cancer: An avenue for chemoprevention
- (2011) Paola Muti et al. CELL CYCLE
- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- Regulation of the expression balance of angiopoietin-1 and angiopoietin-2 by Shh and FGF-2
- (2010) Takaaki Fujii et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Anti-angiogenic therapy: Adapting strategies to overcome resistant tumors
- (2010) Dianne C. Mitchell et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide
- (2010) Xiang Chen et al. JOURNAL OF CONTROLLED RELEASE
- Differential Phosphoproteomics of Fibroblast Growth Factor Signaling: Identification of Src Family Kinase-Mediated Phosphorylation Events
- (2010) Debbie L. Cunningham et al. JOURNAL OF PROTEOME RESEARCH
- The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases
- (2010) R. S. Bhide et al. MOLECULAR CANCER THERAPEUTICS
- Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases
- (2010) Jae Hyun Bae et al. MOLECULES AND CELLS
- Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib
- (2010) J C Welti et al. ONCOGENE
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to targeted therapy in renal-cell carcinoma
- (2009) Brian I Rini et al. LANCET ONCOLOGY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- A pro-inflammatory signature mediates FGF2-induced angiogenesis
- (2008) Germán Andrés et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Fibroblast growth factor 2-induced angiogenesis in zebrafish: the zebrafish yolk membrane (ZFYM) angiogenesis assay
- (2008) Stefania Nicoli et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
- (2008) Kristian Pietras et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More